1. Home
  2. SHAK vs PVLA Comparison

SHAK vs PVLA Comparison

Compare SHAK & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shake Shack Inc.

SHAK

Shake Shack Inc.

HOLD

Current Price

$71.13

Market Cap

2.3B

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$157.77

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHAK
PVLA
Founded
2004
2015
Country
United States
United States
Employees
N/A
29
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
SHAK
PVLA
Price
$71.13
$157.77
Analyst Decision
Buy
Strong Buy
Analyst Count
26
15
Target Price
$117.29
$171.87
AVG Volume (30 Days)
2.2M
187.1K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
354.17
N/A
EPS
0.37
N/A
Revenue
$1,445,306,000.00
N/A
Revenue This Year
$16.58
N/A
Revenue Next Year
$15.07
$104,350.18
P/E Ratio
$190.05
N/A
Revenue Growth
15.38
N/A
52 Week Low
$51.60
$40.22
52 Week High
$110.67
$161.38

Technical Indicators

Market Signals
Indicator
SHAK
PVLA
Relative Strength Index (RSI) 66.47 58.21
Support Level $52.90 $103.38
Resistance Level $97.35 $156.88
Average True Range (ATR) 2.90 11.69
MACD 1.48 0.41
Stochastic Oscillator 79.32 86.10

Price Performance

Historical Comparison
SHAK
PVLA

About SHAK Shake Shack Inc.

Shake Shack Inc is a roadside burger stand. It serves a classic American menu of premium burgers, hot dogs, crispy chicken, frozen custard, crinkle-cut fries, shakes, beer, wine, and more. The company's burgers are made with a whole-muscle blend of all-natural, hormone and antibiotic-free Angus beef, ground fresh daily, cooked to order, and served on a non-genetically modified organism (GMO) potato bun. Its menu focuses on food and beverages, crafted from a range of classic American foods. The company serves draft Root Beer, seasonal freshly-squeezed lemonade, organic fresh-brewed iced tea, cold brew coffee, organic apple juice, and Shack20 bottled water. Geographically, the company generates the majority of its revenue from the United States.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Share on Social Networks: